Clinical Trials Sponsored by Ceruvia Lifesciences

Total 552 results

GEn1E Lifesciences

Completed

Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124

Healthy

New Zealand
Edwards Lifesciences

Completed

MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS) (MITRAFIT)

Mitral Regurgitation

Germany, Italy
Edwards Lifesciences

Completed

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7 (PII S3HR/NR7)

Symptomatic Severe Aortic Stenosis

United States, Canada
Edwards Lifesciences

Completed

SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice (SOURCE 3)

Aortic Stenosis

United Kingdom, Denmark, Germany, Switzerland, France, Netherlands, Finland, Italy, Slovakia, Spain
Edwards Lifesciences

Completed

PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

Aortic Valve Stenosis

United Kingdom, Germany, France, Austria
Edwards Lifesciences

Completed

SOURCE XT REGISTRY

Severe Aortic Stenosis

Spain, Italy, Canada, Belgium, Greece, Germany, Austria, United Kingdom, Finland, Denmark, France, Switzerland, Israel, Poland, South Africa, Czechia, Netherlands, Norway
Edwards Lifesciences

Unknown

Hypotension Prediction Index Study (HPI Study)

Hypotension

United States
Edwards Lifesciences

Active, not recruiting

Edwards PASCAL Transcatheter Valve Repair System Registry (PASCALRegistry)

Mitral Valve Insufficiency

Switzerland, Germany
Edwards Lifesciences

Completed

Magna Mitral - 23mm

Mitral Heart Valve Disease

United States, Poland
Edwards Lifesciences

Unknown

CLEAR Sepsis Clinical Study (CLEAR Sepsis)

Sepsis

United States
Edwards Lifesciences

Completed

ClearSight System CHN Study

Patient With Clinically Indicated Invasive Monitoring

China
Edwards Lifesciences

Completed

Assisted Fluid Management IDE Study (AFM)

Abdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular Surgery

United States
ReShape Lifesciences

Active, not recruiting

The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol (ReNEW)

Obesity, Morbid

United States
Edwards Lifesciences

Completed

Pulmonic Valve REplacement Multi-discIpline EMEA Registry (PREMIER)

Pulmonary Regurgitation | Pulmonary Insufficiency | Pulmonary Stenosis

Germany, Ireland, Belgium, Israel, United Kingdom, Italy, Poland, Saudi Arabia, Turkey
ReShape Lifesciences

Unknown

The Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity (ReCharge)

Obesity

United States, Australia
Edwards Lifesciences

Withdrawn

Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)

Cardiovascular Disease | Heart Disease | Heart Valve Disease | Mitral Insufficiency
Edwards Lifesciences

Terminated

V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse

Mitral Leaflet Prolapse

Italy
Edwards Lifesciences

Completed

Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Emergently Admitted to the Intensive Care Unit Who Are Hemodynamically Unstable

Cardiac Output, Low | Cardiac Output, High

Switzerland, Finland
JSW Lifesciences

Terminated

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

Alzheimer´s Disease
Zydus Lifesciences Limited

Recruiting

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Ulcerative Colitis

India
Zydus Lifesciences Limited

Not yet recruiting

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

Asymptomatic Condition | Falciparum Malaria | Uncomplicated Malaria
Integra LifeSciences Corporation

Recruiting

External Ventricular Drainage Post-Market Clinical Follow-up Registry

Cerebrospinal; Disorder

Belgium, France
Zydus Lifesciences Limited

Recruiting

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

Chronic Kidney Diseases | Anemia of Chronic Kidney Disease

India
Integra LifeSciences Corporation

Completed

Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair

Ventral Hernia

United States
SignalChem Lifesciences Corporation

Completed

Safety Study of SLC-391 in Subjects With Solid Tumors

Solid Tumor

Canada
Enzychem Lifesciences Corporation

Completed

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Febrile Neutropenia

Korea, Republic of
Integra LifeSciences Corporation

Withdrawn

The CUSA Clarity Bone Tip Study

Cranial Skull Base Bone Removal

Italy, Germany, Greece
Optimapharm
Edwards Lifesciences

Active, not recruiting

RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis) (RHEIA)

Aortic Valve Stenosis | Heart Valve Diseases

United Kingdom, Italy, Germany, France, Austria, Switzerland, Finland, Czechia, Belgium, Netherlands, Cyprus, Ireland
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

Healthy

India
Integra LifeSciences Corporation

Completed

A Study on the Safety of Hakim Programmable Shunt System

Hydrocephalus

China
Zydus Lifesciences Limited

Completed

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

Healthy

India
Integra LifeSciences Corporation

Completed

Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

Surgery | Dura Mater Nick Cut or Tear

France, Spain, United Kingdom, Germany
Integra LifeSciences Corporation

Completed

Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant (CUSTOMBONE)

Surgery

France
Integra LifeSciences Corporation

Terminated

A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers

Foot Ulcer, Diabetic

United States, Puerto Rico
Integra LifeSciences Corporation

Terminated

DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

Spinal Injuries | Adhesions

United States
Integra LifeSciences Corporation

Completed

Study to Evaluate Safety and Effectiveness of Spinal Sealant

Spinal Procedure Requiring Dura Incision

United States
Integra LifeSciences Corporation

Terminated

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix (HEALED)

Foot Ulcer, Diabetic

United States, Puerto Rico
Enzychem Lifesciences Corporation

Completed

Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers

Chemotherapy-Induced Neutropenia

Korea, Republic of
Enzychem Lifesciences Corporation

Completed

Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers

Chemotherapy-Induced Neutropenia

Korea, Republic of
Integra LifeSciences Services

Withdrawn

Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis

Arthritis

Portugal, Netherlands, Spain, France, Belgium, United Kingdom, Italy
Mespere Lifesciences Inc.

Completed

Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin

Healthy Volunteers

United States
Integra LifeSciences Corporation

Not yet recruiting

Bactiseal Catheter Safety Registry Study

Hydrocephalus

China
Integra LifeSciences Corporation

Recruiting

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

Brain Tumor | Hemorrhagic Stroke | Hydrocephalus | Hydrocephalus in Children | NPH (Normal Pressure Hydrocephalus) | IIH - Idiopathic Intracranial Hypertension | Post-Traumatic Hydrocephalus

Germany, Belgium
Greenwich LifeSciences, Inc.

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects (FLAMINGO-01)

Breast Cancer

France, United States, Spain, Germany, Italy, Poland
Integra LifeSciences Corporation

Recruiting

The SurgiMend PRS Retrospective Study

Reconstructive Surgical Procedures

United Kingdom, Switzerland, Italy
Integra LifeSciences Corporation

Recruiting

The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of IVH

Subarachnoid Hemorrhage | Intraventricular Hemorrhage

United States
Integra LifeSciences Corporation

Terminated

NeuraGen 3D Pilot Study

Digital Nerve Injury

United States
Integra LifeSciences Corporation

Active, not recruiting

Suturable DuraGen™ PMCF Study

Cerebrospinal Fluid Leak

United States
Integra LifeSciences Corporation

Completed

T-GENVIH-003 LTFU (Long Term Follow Up) Study

Hernia | Pathological Conditions, Anatomical | Hernia, Abdominal | Hernia, Ventral

United States
Enzychem Lifesciences Corporation

Completed

To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia

COVID-19

Korea, Republic of

Clinical Trials Sponsored by Ceruvia Lifesciences

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations